Trial Profile
Safety and Immunogenicity of Sabin-IPV and Adjuvanted Sabin-IPV in Healthy Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Apr 2014
Price :
$35
*
At a glance
- Drugs Poliovirus vaccine Intravacc/WHO (Primary) ; Poliovirus vaccine inactivated
- Indications Poliomyelitis
- Focus Adverse reactions
- 12 Sep 2013 Results published in Vaccine.
- 13 Nov 2012 New trial record